UPL (UPL) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
5 Aug, 2026Executive summary
Achieved seventh consecutive quarter of revenue and EBITDA growth, with Q1 FY27 delivering the strongest Q1 net income in three years despite macroeconomic and geopolitical challenges.
Margin expansion continued, driven by improved business quality, favorable pricing actions, and disciplined execution across key geographies.
Maintained resilience and broad-based growth across all business platforms and geographies, overcoming weather, supply chain, and input cost headwinds; specialty chemicals and Advanta segments showed robust performance.
Consolidated revenue for Q1 FY27 was ₹10,181 crore, up 10.5% year-over-year but down 44.5% sequentially from Q4 FY26.
Net loss for the quarter was ₹73 crore, compared to a net profit of ₹1,294 crore in Q4 FY26 and a net loss of ₹176 crore in Q1 FY26.
Financial highlights
Q1 FY27 revenue rose 10% year-over-year to INR 10,181 crore, driven by 3% positive pricing and favorable exchange, offset by 3% volume decline.
EBITDA for Q1 FY27 was ₹1,500 crore, up 15% year-over-year, with margin improving 60 bps to 14.7%.
Contribution margin expanded to 45.2%, with contribution up 15% to INR 4,607 crore.
PATMI turned positive at INR 10 crore (from -INR 88 crore YoY), but reported net loss of ₹73 crore due to margin pressures and restructuring costs.
Net debt-to-EBITDA improved to 2.4x; net debt-to-equity stable at 0.6x; net debt increased to ₹23,649 crore due to seasonal working capital.
Outlook and guidance
Full-year FY27 guidance: revenue growth of 7%-11%, EBITDA growth of 10%-14%.
Expect strong Q2 led by volume recovery, new product launches, and continued operational excellence.
Strategic priorities include margin improvement, PATMI growth, deleveraging, and enhanced returns.
The company is undergoing major restructuring, including amalgamation and demerger of key business units, with regulatory approvals in progress.
Cautious outlook for agrochemicals due to ongoing geopolitical and weather uncertainties, but confident in resilient core and innovation.
Latest events from UPL
- FY26 saw record revenue, profit, margin gains, and deleveraging, with a 300% dividend proposed.UPL
Q4 25/26 & CMD 2026 - Reorganization creates a focused, listed crop protection leader with enhanced value and efficiency.UPL
Investor presentation - Q3 FY26 revenue rose 12%, EBITDA grew 13%, and net debt was significantly reduced.UPL
Q3 25/26 - Q2 FY26 saw robust profit recovery, margin expansion, and upgraded EBITDA guidance.UPL
Q2 2026 - Double-digit EBITDA growth and margin expansion achieved despite a quarterly net loss.UPL
Q1 25/26 - Q1 FY25 saw ₹9,067 crore revenue, a net loss of ₹965 crore, and a rights issue approved.UPL
Q1 24/25 - Q2 FY2025 saw strong volume growth and lower net debt, but margins declined on pricing pressure.UPL
Q2 24/25 - Record FY25 profit, EBITDA growth, and deleveraging set stage for continued margin expansion.UPL
Q4 & Investor Day 24/25 - Q3 FY25 saw strong profit recovery, margin expansion, and significant debt reduction.UPL
Q3 24/25